Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial
NCT04359264 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 392
Last updated 2020-07-07
Summary
This is a clinical trial of a cash transfer on symptoms consistent with COVID-19 and adherence to physical distancing guidance.
Conditions
Interventions
- OTHER
-
Cash transfer
Cash transfer of $1000
Sponsors & Collaborators
-
Unity Health Toronto
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-20
- Primary Completion
- 2020-05-29
- Completion
- 2020-12-30
Countries
- Canada
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults
NCT05437289 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
NCT04625725 ·Status: COMPLETED ·Phase: PHASE3
-
A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.
NCT01091532 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
NCT07057726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
NCT00791752 ·Status: COMPLETED ·Phase: PHASE1
-
First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males
NCT06094283 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers
NCT00726427 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects
NCT01818869 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants
NCT04609852 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy Volunteers
NCT00803855 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects
NCT01247103 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers
NCT00940212 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants
NCT05003713 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy Volunteers
NCT00997308 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers
NCT01480310 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study
NCT00755378 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects
NCT03183739 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers
NCT02596399 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MCAF5352A in Healthy Volunteers
NCT01540760 ·Status: COMPLETED ·Phase: PHASE1
-
Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal
NCT05256732 ·Status: COMPLETED ·Phase: PHASE1
-
Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects
NCT01166698 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
NCT00767052 ·Status: COMPLETED ·Phase: PHASE1
-
First-in-human Study in Healthy Subjects
NCT03315338 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects
NCT03435276 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects
NCT00796965 ·Status: COMPLETED ·Phase: PHASE1